Sankey It
Loading...
Eli Lilly and Company Q3 FY2025 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company Q3 FY2025 income statement
USD · quarter ended 2025-09-30
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company Q3 FY2025 income statement
Flow diagram with 8 nodes and 7 flows for Eli Lilly and Company Q3 FY2025 income statement. Values: Revenue US$17.6B, Cost of Revenue US$3B, Gross Profit US$14.6B, Operating Expenses US$6.2B, Operating Income US$8.4B, Other Expense US$1.2B, Tax US$1.6B, Net Income US$5.6B.
Revenue
US$17.6B
Cost of Revenue
(US$3B)
17% of revenue
Gross Profit
US$14.6B
83% margin
Operating Expenses
(US$6.2B)
35% of revenue
Operating Income
US$8.4B
48% margin
Other Expense
(US$1.2B)
7% of revenue
Tax
(US$1.6B)
9% of revenue
Net Income
US$5.6B
32% margin
Net / profit
Tax / cost
Copy link
Share on X
Open full screen